Announcements

In September, the WHO-recognized Childhood Cancer Awareness Month features global activities to raise awareness and support for childhood cancer research. We would like to take this opportunity to extend our appreciation to all of the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of childhood cancer that have been published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for all individuals interested in this field.

“Association of Insulin-like Growth Factor-1 with Bone Mineral Density in Survivors of Childhood Acute Leukemia”
by Seulki Kim, Jae Won Yoo, Jae Wook Lee, Min Ho Jung, Bin Cho, Byng-Kyu Suh, Moon Bae Ahn and Nack-Gyun Chung
Cancers 2024, 16(7), 1296; https://doi.org/10.3390/cancers16071296

“Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia”
by Jiasen He, Faryal Munir, Samanta Catueno, Jeremy S. Connors, Amber Gibson, Lindsay Robusto, David McCall, Cesar Nunez, Michael Roth, Priti Tewari et al.
Cancers 2024, 16(5), 858; https://doi.org/10.3390/cancers16050858

“Causes of Childhood Cancer: A Review of the Recent Literature: Part I—Childhood Factors”
by Angela M. Ricci, Rebecca T. Emeny, Pamela J. Bagley, Heather B. Blunt, Mary E. Butow, Alexandra Morgan, Jennifer A. Alford-Teaster, Linda Titus, Raymond R. Walston, III and Judy R. Rees
Cancers 2024, 16(7), 1297; https://doi.org/10.3390/cancers16071297

“Childhood Cancer Incidence and Survival in South Australia and the Northern Territory, 1990–2017, with Emphasis on Indigenous Peoples”
by Suzanne Mashtoub, Shahid Ullah, Anne Collinson, Gurmeet R. Singh, Justine Clark (Adnyamathanha), Shalem Leemaqz, Ora Paltiel, David M. Roder, Benjamin Saxon, Ross McKinnon et al.
Cancers 2024, 16(11), 2057; https://doi.org/10.3390/cancers16112057

“Chimeric Antigen Receptor T Cell and Chimeric Antigen Receptor NK Cell Therapy in Pediatric and Adult High-Grade Glioma—Recent Advances”
by Adrian Kowalczyk, Julia Zarychta, Anna Marszołek, Joanna Zawitkowska and Monika Lejman
Cancers 2024, 16(3), 623; https://doi.org/10.3390/cancers16030623

“Extracellular Vesicles for Childhood Cancer Liquid Biopsy”
by Nilubon Singhto, Pongpak Pongphitcha, Natini Jinawath, Suradej Hongeng and Somchai Chutipongtanate
Cancers 2024, 16(9), 1681; https://doi.org/10.3390/cancers16091681

“Immune Microenvironment in Childhood Cancers: Characteristics and Therapeutic Challenges”
by Anup Singh Pathania
Cancers 2024, 16(12), 2201; https://doi.org/10.3390/cancers16122201

“Pediatric Diffuse Midline Glioma H3K27-Altered: From Developmental Origins to Therapeutic Challenges”
by Manuela Mandorino, Ahana Maitra, Domenico Armenise, Olga Maria Baldelli, Morena Miciaccia, Savina Ferorelli, Maria Grazia Perrone and Antonio Scilimati
Cancers 2024, 16(10), 1814; https://doi.org/10.3390/cancers16101814

“Therapeutic Parent–Child Communication and Health Outcomes in the Childhood Cancer Context: A Scoping Review”
by Heeyeon Son and Nani Kim
Cancers 2024, 16(11), 2152; https://doi.org/10.3390/cancers16112152

“Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective”
by Hiroshi Hayashi, Atsushi Makimoto and Yuki Yuza
Cancers 2024, 16(4), 723; https://doi.org/10.3390/cancers16040723

“New Advances in the Treatment of Pediatric Solid Tumors” Guest Editors: Prof. Dr. Myriam Weyl Ben-Arush and Dr. Oz Mordechai Submission deadline: 20 November 2025	“Pediatric Cancer Research from Basic Biology to Experimental Therapy” Guest Editor: Prof. Dr. Atif Ahmed Submission deadline: 16 January 2026

“Pediatric Cancers” Edited by Saurabh Agarwal and Jianhua Yang https://doi.org/10.3390/books978-3-0365-9025-7 This is a Reprint of the Special Issue “Pediatric Cancers” that was published in Cancers.

MDPI will attend ASN Kidney Week 2025, which will take place from 6 to 9 November 2025, at the George R. Brown Convention Center, in Houston, USA.

The American Society of Nephrology (ASN) invites you to participate in the largest and most influential international gathering of kidney professionals worldwide. Join the kidney community as we come together with a shared focus on improving the lives of over 850 million people across the globe. At Kidney Week 2025 in Houston, TX, you will have the opportunity to engage with more than 12,000 kidney professionals and experience the Scientific Exposition, which showcases the latest advances in treatment, research, and cutting-edge technology in nephrology. As the world’s premier nephrology meeting, Kidney Week offers exciting and challenging opportunities to exchange knowledge, discover the newest scientific and medical developments, and take part in engaging discussions with leading experts in the field.

MDPI is excited to participate in this prestigious event. We welcome you to visit MDPI’s booth, where you will be able to have face-to-face exchanges with our representatives, and learn more about our open access publishing services.

The following MDPI journals will be represented:

• Kidney and Dialysis;
• Applied Biosciences;
• Biomedicines;
• Cancers;
• Cells;
• Children;
• Clinics and Practice;
• Diabetology;
• Diseases;
• Genes;
• Healthcare;
• IJERPH;
• IJTM;
• Immuno;
• J;
• JMP;
• JPM;
• Life;
• Medical Sciences;
• Metabolites;
• Sci. Pharm.;
• Therapeutics;
• Transplantology;
• Vaccines.

If you plan to attend this event, we encourage you to visit our booth and speak to our representatives. We are eager to meet you in person and assist you with any queries that you may have. For more information about the conference, please visit the official website: https://www.asn-online.org/kidneyweek.

Cancers (ISSN: 2072-6694) is an open access journal, thus granting our readers free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to cancer epidemiology and prevention in 2024, which are listed below:

1. “Distribution during the COVID-19 Pandemic in Patients with Head and Neck Squamous Cell Carcinoma at a Large Hungarian Cancer Center”
by Éva Szabó, Eszter Kopjár, László Rumi, Árpád Boronkai, Szabolcs Bellyei, Zoltán Gyöngyi, Antal Zemplényi, Balázs Sütő, János Girán, István Kiss et al.
Cancers 2024, 16(14), 2570; https://doi.org/10.3390/cancers16142570
Available online: https://www.mdpi.com/2072-6694/16/14/2570

2. “Meta-Analysis of Age, Sex, and Race Disparities in the Era of Contemporary Urothelial Carcinoma Treatment”
by Adam Barsouk, Omar Elghawy, Austin Yang, Jonathan H. Sussman, Ronac Mamtani and Lin Mei
Cancers 2024, 16(19), 3228; https://doi.org/10.3390/cancers16193338
Available online: https://www.mdpi.com/2072-6694/16/19/3338

3. “Impact of Age, Period, Cohort, Region, Race, and Health Services on Bladder Cancer Mortality in Brazil: A 23-Year Ecological Study”
by João Simão de Melo Neto, Sâmia Feitosa Miguez, Amanda Lia Rebelo Rabel, Amanda Marinho da Silva, Daniel Souza Sacramento, Dária Barroso Serrão das Neves, Iana Nogueira Rego, Riter Lucas Miranda Garcia, Deizyane dos Reis Galhardo and André Luiz Machado das Neves
Cancers 2024, 16(17), 3028; https://doi.org/10.3390/cancers16173038
Available online: https://www.mdpi.com/2072-6694/16/17/3038

4. “Cancer-Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK Yellow Card Adverse Drug Reaction (ADR) Reporting”
by Stefanie Ho Yi Chan, Deborah Layton, Sherael Webley and Sam Salek
Cancers 2024, 16(24), 4223; https://doi.org/10.3390/cancers16244223
Available online: https://www.mdpi.com/2072-6694/16/24/4223

5. “Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis”
by Agnieszka Drab, Krystian Wdowiak, Wiesław Kanadys, Krzysztof Zajączkowski, Paweł Koczkodaj, Urszula Religioni, Mariola Borowska, Magdalena Łoś and Macarena Lozano-Lorca
Cancers 2024, 16(23), 4010; https://doi.org/10.3390/cancers16234010
Available online: https://www.mdpi.com/2072-6694/16/23/4010

6. “Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective”
by Rahul Ladwa, Gerald Fogarty, Peggy Chen, Gurpreet Grewal, Chris McCormack, Victoria Mar, Delphine Kerob and Kiarash Khosrotehrani
Cancers 2024, 16(14), 2526; https://doi.org/10.3390/cancers16142526
Available online: https://www.mdpi.com/2072-6694/16/14/2526

7. “Comparative Analysis of AML Classification Systems: Evaluating the WHO, ICC, and ELN Frameworks and Their Distinctions”
by Huda Salman
Cancers 2024, 16(16), 2915; https://doi.org/10.3390/cancers16162915
Available online: https://www.mdpi.com/2072-6694/16/16/2915

8. “Benign and Malignant Outcomes in the Offspring of Females Exposed In Utero to Diethylstilbestrol (DES): An Update from the NCI Third Generation Study”
by Linda Titus, Elizabeth E. Hatch, Kimberly A. Bertrand, Julie R. Palmer, William C. Strohsnitter, Dezheng Huo, Michael Curry, Marianne Hyer, Kjersti Aagaard, Gretchen L. Gierach et al.
Cancers 2024, 16(14), 2575; https://doi.org/10.3390/cancers16142575
Available online: https://www.mdpi.com/2072-6694/16/14/2575

9. “Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes”
by Paraskevi Apostolou, Vasiliki Dellatola, Athanasios Papathanasiou, Despoina Kalfakakou, Elena Fountzilas, Dimitrios Tryfonopoulos, Sofia Karageorgopoulou, Drakoulis Yannoukakos, Irene Konstantopoulou and Florentia Fostira
Cancers 2024, 16(13), 2368; https://doi.org/10.3390/cancers16132368
Available online: https://www.mdpi.com/2072-6694/16/13/2368

10. “Gastric Epithelial Polyps: Current Diagnosis, Management, and Endoscopic Frontiers”
by Diego Reyes-Placencia, Elisa Cantú-Germano, Gonzalo Latorre, Alberto Espino, Glòria Fernández-Esparrach and Leticia Moreira
Cancers 2024, 16(22), 3771; https://doi.org/10.3390/cancers16223771
Available online: https://www.mdpi.com/2072-6694/16/22/3771

You can view more papers and submit your own manuscript to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As all the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our notable papers in the field of blood cancer, which are listed below:

“Venetoclax Resistance in Acute Myeloid Leukemia”
by Sylvain Garciaz, Marie-Anne Hospital, Yves Collette and Norbert Vey
Cancers 2024, 16(6), 1091; https://doi.org/10.3390/cancers16061091
Available online: https://www.mdpi.com/2072-6694/16/6/1091

“Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective”
by Hiroshi Hayashi, Atsushi Makimoto and Yuki Yuza
Cancers 2024, 16(4), 723; https://doi.org/10.3390/cancers16040723
Available online: https://www.mdpi.com/2072-6694/16/4/723

“JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature”
by Seyed Mohammad Vahabi, Saeed Bahramian, Farzad Esmaeili, Bardia Danaei, Yasamin Kalantari, Patrick Fazeli, Sara Sadeghi, Nima Hajizadeh, Chalid Assaf and Ifa Etesami
Cancers 2024, 16(5), 861; https://doi.org/10.3390/cancers16050861
Available online: https://www.mdpi.com/2072-6694/16/5/861

“Evaluating Outcome Prediction via Baseline, End-of-Treatment, and Delta Radiomics on PET-CT Images of Primary Mediastinal Large B-Cell Lymphoma”
by Fereshteh Yousefirizi, Claire Gowdy, Ivan S. Klyuzhin, Maziar Sabouri, Petter Tonseth, Anna R. Hayden, Donald Wilson, Laurie H. Sehn, David W. Scott, Christian Steidl et al.
Cancers 2024, 16(6), 1090; https://doi.org/10.3390/cancers16061090
Available online: https://www.mdpi.com/2072-6694/16/6/1090

“Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment”
by Fauzia Ullah, Mariam Markouli, Mark Orland, Olisaemeka Ogbue, Danai Dima, Najiullah Omar and Moaath K. Mustafa Ali
Cancers 2024, 16(7), 1307; https://doi.org/10.3390/cancers16071307
Available online: https://www.mdpi.com/2072-6694/16/7/1307

“Adverse In-Hospital Outcomes after Radical Prostatectomy in Leukemia History Patients”
by Fabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, Mattia Longoni, Andrea Marmiroli, Quynh Chi Le, Zhe Tian, Jordan A. Goyal, Nicola Longo, Salvatore Micali et al.
Cancers 2024, 16(15), 2764; https://doi.org/10.3390/cancers16152764
Available online: https://www.mdpi.com/2072-6694/16/15/2764

“Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas”
by Francesco D’Alò, Silvia Bellesi, Elena Maiolo, Eleonora Alma, Flaminia Bellisario, Rosalia Malafronte, Marcello Viscovo, Fabrizia Campana and Stefan Hohaus
Cancers 2024, 16(12), 2243; https://doi.org/10.3390/cancers16122243
Available online: https://www.mdpi.com/2072-6694/16/12/2243

“Chimeric Antigen Receptor (CAR) T-Cell Therapy in Hematologic Malignancies: Clinical Implications and Limitations”
by Philipp Blüm and Sabine Kayser
Cancers 2024, 16(8), 1599; https://doi.org/10.3390/cancers16081599
Available online: https://www.mdpi.com/2072-6694/16/8/1599

“Enhancing Lymphoma Diagnosis, Treatment, and Follow-Up Using ¹⁸F-FDG PET/CT Imaging: Contribution of Artificial Intelligence and Radiomics Analysis”
by Setareh Hasanabadi, Seyed Mahmud Reza Aghamiri, Ahmad Ali Abin, Hamid Abdollahi, Hossein Arabi and Habib Zaidi
Cancers 2024, 16(20), 3511; https://doi.org/10.3390/cancers16203511
Available online: https://www.mdpi.com/2072-6694/16/20/3511

“T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies”
by Paweł Cech, Katarzyna Skórka, Laura Dziki and Krzysztof Giannopoulos
Cancers 2024, 16(8), 1580; https://doi.org/10.3390/cancers16081580
Available online: https://www.mdpi.com/2072-6694/16/8/1580

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

Cancers (ISSN: 2072-6694) is an open access journal, thus granting our readers free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to cancer immunology and immunotherapy in 2024, which are listed below:

1. “Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations”
by Silvia Casagrande, Giulia Boscato Sopetto, Giovanni Bertalot, Roberto Bortolotti, Vito Racanelli, Orazio Caffo, Bruno Giometto, Alvise Berti and Antonello Veccia
Cancers 2024, 16(7), 1440; https://doi.org/10.3390/cancers16071440
Available online: https://www.mdpi.com/2072-6694/16/7/1440

2. “Syngeneic Mouse Models for Pre-Clinical Evaluation of CAR T Cells”
by Eman N. Ahmed, Lauren C. Cutmore and John F. Marshall
Cancers 2024, 16(18), 3186; https://doi.org/10.3390/cancers16183186
Available online: https://www.mdpi.com/2072-6694/16/18/3186

3. “T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies”
by Paweł Cech, Katarzyna Skórka, Laura Dziki and Krzysztof Giannopoulos
Cancers 2024, 16(8), 1580; https://doi.org/10.3390/cancers16081580
Available online: https://www.mdpi.com/2072-6694/16/8/1580

4. “Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting”
by Edoardo Crimini, Luca Boscolo Bielo, Pier Paolo Maria Berton Giachetti, Gloria Pellizzari, Gabriele Antonarelli, Beatrice Taurelli Salimbeni, Matteo Repetto, Carmen Belli and Giuseppe Curigliano
Cancers 2024, 16(2), 281; https://doi.org/10.3390/cancers16020281
Available online: https://www.mdpi.com/2072-6694/16/2/281

5. “Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer”
by Alexander Sebastian Franzén, Abdelhadi Boulifa, Clarissa Radecke, Sebastian Stintzing, Martin J. Raftery and Gabriele Pecher
Cancers 2024, 16(2), 388; https://doi.org/10.3390/cancers16020388
Available online: https://www.mdpi.com/2072-6694/16/2/388

6. “MICA+ Tumor Cell Upregulated Macrophage-Secreted MMP9 via PROS1-AXL Axis to Induce Tumor Immune Escape in Advanced Hepatocellular Carcinoma (HCC)”
by Qiulin Wu, Xicai Li, Yan Yang, Jingquan Huang, Ming Yao, Jianjun Li, Yubin Huang, Xiaoyong Cai, David A. Geller and Yihe Yan
Cancers 2024, 16(2), 269; https://doi.org/10.3390/cancers16020269
Available online: https://www.mdpi.com/2072-6694/16/2/269

7. “Targeting Siglec–Sialylated MUC1 Immune Axis in Cancer”
by Ramya Ayyalasomayajula and Mare Cudic
Cancers 2024, 16(7), 1334; https://doi.org/10.3390/cancers16071334
Available online: https://www.mdpi.com/2072-6694/16/7/1334

8. “Impact of Nutritional Status on Neutrophil-to-Lymphocyte Ratio as a Predictor of Efficacy and Adverse Events of Immune Check-Point Inhibitors”
by Masahiko Sue, Yasuto Takeuchi, Shoichiro Hirata, Akinobu Takaki and Motoyuki Otsuka
Cancers 2024, 16(10), 1811; https://doi.org/10.3390/cancers16101811
Available online: https://www.mdpi.com/2072-6694/16/10/1811

9. “Checkpoint Inhibitors in Dogs: Are We There Yet?”
by Antonio Giuliano, Pedro A. B. Pimentel and Rodrigo S. Horta
Cancers 2024, 16(11), 2003; https://doi.org/10.3390/cancers16112003
Available online: https://www.mdpi.com/2072-6694/16/11/2003

10. “The Role of YY1 in the Regulation of LAG-3 Expression in CD8 T Cells and Immune Evasion in Cancer: Therapeutic Implications”
by Adam Merenstein, Loiy Obeidat, Apostolos Zaravinos and Benjamin Bonavida
Cancers 2024, 17(1), 19; https://doi.org/10.3390/cancers17010019
Available online: https://www.mdpi.com/2072-6694/17/1/19

You can view more papers and submit your own manuscript to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

Cancers (ISSN: 2072-6694) is an open access journal, thus granting our readers free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to clinical research of cancer in 2024, which are listed below:

1. “Venetoclax Resistance in Acute Myeloid Leukemia”
by Sylvain Garciaz, Marie-Anne Hospital, Yves Collette and Norbert Vey
Cancers 2024, 16(6), 1091; https://doi.org/10.3390/cancers16061091
Available online: https://www.mdpi.com/2072-6694/16/6/1091

2. “Emerging Therapies for Glioblastoma”
by Stella Aimé Rios, Stephanie Oyervides, David Uribe, Angelica Maree Reyes, Victor Fanniel, Jonathan Vazquez and Megan Keniry
Cancers 2024, 16(8), 1485; https://doi.org/10.3390/cancers16081485
Available online: https://www.mdpi.com/2072-6694/16/8/1485

3. “Gastric Cancer: An Up-to-Date Review with New Insights into Early-Onset Gastric Cancer”
by Marek Mazurek, Monika Szewc, Monika Z. Sitarz, Ewa Dudzińska and Robert Sitarz
Cancers 2024, 16(18), 3163; https://doi.org/10.3390/cancers16183163
Available online: https://www.mdpi.com/2072-6694/16/18/3163

4. “Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma”
by Sami Fares, Chase J. Wehrle, Hanna Hong, Keyue Sun, Chunbao Jiao, Mingyi Zhang, Abby Gross, Erlind Allkushi, Melis Uysal, Suneel Kamath et al.
Cancers 2024, 16(8), 1453; https://doi.org/10.3390/cancers16081453
Available online: https://www.mdpi.com/2072-6694/16/8/1453

5. “Inflammation and Related Signaling Pathways in Acute Myeloid Leukemia”
by Nour Sabiha Naji, Mrudula Sathish and Theodoros Karantanos
Cancers 2024, 16(23), 3974; https://doi.org/10.3390/cancers16233974
Available online: https://www.mdpi.com/2072-6694/16/23/3974

6. “Learning Curve for Robotic Colorectal Surgery”
by Neng Wei Wong, Nan Zun Teo and James Chi-Yong Ngu
Cancers 2024, 16(19), 3420; https://doi.org/10.3390/cancers16193420
Available online: https://www.mdpi.com/2072-6694/16/19/3420

7. “Overall Survival and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A National Cancer Database Analysis”
by Meghana Kesireddy, Lina Elsayed, Valerie K. Shostrom, Priyal Agarwal, Samia Asif, Amulya Yellala and Jairam Krishnamurthy
Cancers 2024, 16(10), 1791; https://doi.org/10.3390/cancers16101791
Available online: https://www.mdpi.com/2072-6694/16/10/1791

8. “Targeted Therapies and Drug Resistance in Advanced Breast Cancer, Alternative Strategies and the Way beyond”
by Andrea Nicolini and Paola Ferrari
Cancers 2024, 16(2), 466; https://doi.org/10.3390/cancers16020466
Available online: https://www.mdpi.com/2072-6694/16/2/466

9. “Deferral of Treatment for Small Choroidal Melanoma and the Risk of Metastasis: An Investigation Using the Liverpool Uveal Melanoma Prognosticator Online (LUMPO)”
by Bertil Damato, Antonio Eleuteri, Azzam Taktak, Rumana Hussain, Maria Fili, Gustav Stålhammar, Heinrich Heimann and Sarah E. Coupland
Cancers 2024, 16(8), 1607; https://doi.org/10.3390/cancers16081607
Available online: https://www.mdpi.com/2072-6694/16/8/1607

10. “Diffuse-Type Tenosynovial Giant Cell Tumor: What Are the Important Findings on the Initial and Follow-Up MRI?”
by Woo Suk Choi, Seul Ki Lee, Jee-Young Kim and Yuri Kim
Cancers 2024, 16(2), 402; https://doi.org/10.3390/cancers16020402
Available online: https://www.mdpi.com/2072-6694/16/2/402

You can view more papers and submit your own manuscript to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

Cancers (ISSN: 2072-6694) is an open access journal, thus granting our readers free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to cancer pathophysiology in 2024, which are listed below:

1. “Application of Nanoparticles for Magnetic Hyperthermia for Cancer Treatment—The Current State of Knowledge”
by Marzena Szwed and Agnieszka Marczak
Cancers 2024, 16(6), 1156; https://doi.org/10.3390/cancers16061156
Available online: https://www.mdpi.com/2072-6694/16/6/1156

2. “The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management”
by Andrea Amaroli, Isabella Panfoli, Matteo Bozzo, Sara Ferrando, Simona Candiani and Silvia Ravera
Cancers 2024, 16(14), 2580; https://doi.org/10.3390/cancers16142580
Available online: https://www.mdpi.com/2072-6694/16/14/2580

3. “Liposarcoma: A Journey into a Rare Tumor’s Epidemiology, Diagnosis, Pathophysiology, and Limitations of Current Therapies”
by Emily Jonczak, Julie Grossman, Francesco Alessandrino, Crystal Seldon Taswell, Jaylou M. Velez-Torres and Jonathan Trent
Cancers 2024, 16(22), 3858; https://doi.org/10.3390/cancers16223858
Available online: https://www.mdpi.com/2072-6694/16/22/3858

4. “Angiogenesis Still Plays a Crucial Role in Human Melanoma Progression”
by Gerardo Cazzato, Giuseppe Ingravallo and Domenico Ribatti
Cancers 2024, 16(10), 1794; https://doi.org/10.3390/cancers16101794
Available online: https://www.mdpi.com/2072-6694/16/10/1794

5. “Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges”
by Julianne M. Szczepanski, Mark A. Rudolf and Jiaqi Shi
Cancers 2024, 16(4), 794; https://doi.org/10.3390/cancers16040794
Available online: https://www.mdpi.com/2072-6694/16/4/794

6. “Hereditary Syndromes Associated with Pancreatic and Lung Neuroendocrine Tumors”
by Nektaria Papadopoulou-Marketou, Marina Tsoli, Eleftherios Chatzellis, Krystallenia I. Alexandraki and Gregory Kaltsas
Cancers 2024, 16(11), 2075; https://doi.org/10.3390/cancers16112075
Available online: https://www.mdpi.com/2072-6694/16/11/2075

7. “Soft Tissue Sarcomas with Chromosomal Alterations in the 12q13-15 Region: Differential Diagnosis and Therapeutic Implications”
by Javier Lavernia, Reyes Claramunt, Ignacio Romero, José Antonio López-Guerrero, Antonio Llombart-Bosch and Isidro Machado
Cancers 2024, 16(2), 432; https://doi.org/10.3390/cancers16020432
Available online: https://www.mdpi.com/2072-6694/16/2/432

8. “A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL)”
by Natividad Martínez-Banaclocha, Francisca Martínez-Madueño, Berta Caballé, Joan Badia, Mar Blanes, David Aguiar Bujanda, Virginia Calvo, Jose Gómez Codina, Cristina Quero Blanco, Pablo Espinosa et al.
Cancers 2024, 16(5), 1034; https://doi.org/10.3390/cancers16051034
Available online: https://www.mdpi.com/2072-6694/16/5/1034

9. “Emerging Lipid Targets in Glioblastoma”
by Ammar Darwish, Milán Pammer, Ferenc Gallyas, Jr., László Vígh, Zsolt Balogi and Kata Juhász
Cancers 2024, 16(2), 397; https://doi.org/10.3390/cancers16020397
Available online: https://www.mdpi.com/2072-6694/16/2/397

10. “Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment”
by Nikolaos Vitorakis, Antonios N. Gargalionis, Kostas A. Papavassiliou, Christos Adamopoulos and Athanasios G. Papavassiliou
Cancers 2024, 16(16), 2876; https://doi.org/10.3390/cancers16162876
Available online: https://www.mdpi.com/2072-6694/16/16/2876

You can view more papers and submit your own manuscript to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

September is designated as Prostate Cancer Awareness Month, with various global activities that highlight and increase awareness of prostate cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of prostate cancer, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant papers can be seen below:

“Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer”
by Qiao-Hong Chen, Erick Munoz and Dennis Ashong
Cancers 2024, 16(3), 663; https://doi.org/10.3390/cancers16030663
Available online: https://www.mdpi.com/2072-6694/16/3/663

“Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review”
by Shigekatsu Maekawa, Ryo Takata and Wataru Obara
Cancers 2024, 16(3), 523; https://doi.org/10.3390/cancers16030523
Available online: https://www.mdpi.com/2072-6694/16/3/523

“Emerging Trends in AI and Radiomics for Bladder, Kidney, and Prostate Cancer: A Critical Review”
by Georgios Feretzakis, Patrick Juliebø-Jones, Arman Tsaturyan, Tarik Emre Sener, Vassilios S. Verykios, Dimitrios Karapiperis, Themistoklis Bellos, Stamatios Katsimperis, Panagiotis Angelopoulos, Ioannis Varkarakis et al.
Cancers 2024, 16(4), 810; https://doi.org/10.3390/cancers16040810
Available online: https://www.mdpi.com/2072-6694/16/4/810

“Robot-Assisted Radical Prostatectomy by the Hugo Robotic-Assisted Surgery (RAS) System and the da Vinci System: A Comparison between the Two Platforms”
by Hsien-Che Ou, Lucian Marian, Ching-Chia Li, Yung-Shun Juan, Min-Che Tung, Hung-Jen Shih, Chin-Po Chang, Jian-Ting Chen, Che-Hsueh Yang and Yen-Chuan Ou
Cancers 2024, 16(6), 1207; https://doi.org/10.3390/cancers16061207
Available online: https://www.mdpi.com/2072-6694/16/6/1207

“Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center”
by Angelo Totaro, Eros Scarciglia, Filippo Marino, Marco Campetella, Carlo Gandi, Mauro Ragonese, Riccardo Bientinesi, Giuseppe Palermo, Francesco Pio Bizzarri, Antonio Cretì et al.
Cancers 2024, 16(8), 1602; https://doi.org/10.3390/cancers16081602
Available online: https://www.mdpi.com/2072-6694/16/8/1602

“Transperineal Laser Ablation (TPLA) Treatment of Focal Low–Intermediate Risk Prostate Cancer”
by Gugliemo Manenti, Tommaso Perretta, Marco Nezzo, Federico Romeo Fraioli, Beatrice Carreri, Paola Elda Gigliotti, Andrea Micillo, Andrea Malizia, Daniele Di Giovanni, Colleen Patricia Ryan et al.
Cancers 2024, 16(7), 1404; https://doi.org/10.3390/cancers16071404
Available online: https://www.mdpi.com/2072-6694/16/7/1404

“From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist’s Dual Role in Prostate Cancer”
by Abdulrahman Alhajahjeh, Raad Al-Faouri, Hisham F. Bahmad, Taima’ Bader, Ryan W. Dobbs, Ahmed A. Abdulelah, Wassim Abou-Kheir, Elai Davicioni, David I. Lee and Mohammed Shahait
Cancers 2024, 16(8), 1538; https://doi.org/10.3390/cancers16081538
Available online: https://www.mdpi.com/2072-6694/16/8/1538

“Glutamine Metabolism and Prostate Cancer”
by Holger H. H. Erb, Nikita Polishchuk, Oleh Stasyk, Uğur Kahya, Matthias M. Weigel and Anna Dubrovska
Cancers 2024, 16(16), 2871; https://doi.org/10.3390/cancers16162871
Available online: https://www.mdpi.com/2072-6694/16/16/2871

“Biomarkers for Pre-Treatment Risk Stratification of Prostate Cancer Patients: A Systematic Review”
by José Pedro Sequeira, Sofia Salta, Rui Freitas, Rafael López-López, Ángel Díaz-Lagares, Rui Henrique and Carmen Jerónimo
Cancers 2024, 16(7), 1363; https://doi.org/10.3390/cancers16071363
Available online: https://www.mdpi.com/2072-6694/16/7/1363

“From Despair to Hope: First Arabic Experience of ¹⁷⁷Lu-PSMA and ¹⁶¹Tb-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer”
by Akram Al-Ibraheem, Ahmed Saad Abdlkadir, Deya’ Aldeen Sweedat, Stephan Maus, Ula Al-Rasheed, Samer Salah, Fadi Khriesh, Diyaa Juaidi, Dina Abu Dayek, Feras Istatieh et al.
Cancers 2024, 16(11), 1974; https://doi.org/10.3390/cancers16111974
Available online: https://www.mdpi.com/2072-6694/16/11/1974

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to tumor microenvironment in 2024, which are listed below:

1. “The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway”
by Vasiliki Zoi, Athanassios P. Kyritsis, Vasiliki Galani, Diamanto Lazari, Chrissa Sioka, Spyridon Voulgaris and Georgios A. Alexiou
Cancers 2024, 16(8), 1554; https://doi.org/10.3390/cancers16081554
Available online: https://www.mdpi.com/2072-6694/16/8/1554

2. “TP53 Mutation-Mediated Immune Evasion in Cancer: Mechanisms and Therapeutic Implications”
by Chuqi Wang, Jordan Yong Ming Tan, Nishtha Chitkara and Shruti Bhatt
Cancers 2024, 16(17), 3069; https://doi.org/10.3390/cancers16173069
Available online: https://www.mdpi.com/2072-6694/16/17/3069

3. “Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems”
by Dragana Nikitovic, Ekaterina Kukovyakina, Aikaterini Berdiaki, Alexandros Tzanakakis, Anna Luss, Elizaveta Vlaskina, Anne Yagolovich, Aristides Tsatsakis and Andrey Kuskov
Cancers 2024, 16(22), 3768; https://doi.org/10.3390/cancers16223768
Available online: https://www.mdpi.com/2072-6694/16/22/3768

4. “Heat Shock Proteins, a Double-Edged Sword: Significance in Cancer Progression, Chemotherapy Resistance and Novel Therapeutic Perspectives”
by Dominika Kunachowicz, Magdalena Król-Kulikowska, Wiktoria Raczycka, Jakub Sleziak, Marta Błażejewska and Julita Kulbacka
Cancers 2024, 16(8), 1500; https://doi.org/10.3390/cancers16081500
Available online: https://www.mdpi.com/2072-6694/16/8/1500

5. “Critical Roles of the Sphingolipid Metabolic Pathway in Liver Regeneration, Hepatocellular Carcinoma Progression and Therapy”
by Hiroyuki Nojima, Hiroaki Shimizu, Takashi Murakami, Kiyohiko Shuto and Keiji Koda
Cancers 2024, 16(5), 850; https://doi.org/10.3390/cancers16050850
Available online: https://www.mdpi.com/2072-6694/16/5/850

6. “CSF-1R in Cancer: More than a Myeloid Cell Receptor”
by Francesca Cersosimo, Silvia Lonardi, Cristina Ulivieri, Paolo Martini, Andrea Morrione, William Vermi, Antonio Giordano and Emanuele Giurisato
Cancers 2024, 16(2), 282; https://doi.org/10.3390/cancers16020282
Available online: https://www.mdpi.com/2072-6694/16/2/282

7. “Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment”
by Anghesom Ghebremedhin, Dipti Athavale, Yanting Zhang, Xiaodan Yao, Curt Balch and Shumei Song
Cancers 2024, 16(19), 3410; https://doi.org/10.3390/cancers16193410
Available online: https://www.mdpi.com/2072-6694/16/19/3410

8. “Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells”
by Peter Wai Tik Lee, Lina Rochelle Koseki, Takao Haitani, Hiroshi Harada and Minoru Kobayashi
Cancers 2024, 16(9), 1729; https://doi.org/10.3390/cancers16091729
Available online: https://www.mdpi.com/2072-6694/16/9/1729

9. “HuR (ELAVL1) Stabilizes SOX9 mRNA and Promotes Migration and Invasion in Breast Cancer Cells”
by Jesús Morillo-Bernal, Patricia Pizarro-García, Gema Moreno-Bueno, Amparo Cano, María J. Mazón, Pilar Eraso and Francisco Portillo
Cancers 2024, 16(2), 384; https://doi.org/10.3390/cancers16020384
Available online: https://www.mdpi.com/2072-6694/16/2/384

10. “Therapeutic Potential for Sphingolipids in Inflammatory Bowel Disease and Colorectal Cancer”
by Keila S. Espinoza and Ashley J. Snider
Cancers 2024, 16(4), 789; https://doi.org/10.3390/cancers16040789
Available online: https://www.mdpi.com/2072-6694/16/4/789

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to infectious agents and cancer in 2024, which are listed below:

1. “Cancer and HIV: The Molecular Mechanisms of the Deadly Duo”
by Aadilah Omar, Natasia Marques and Nicole Crawford
Cancers 2024, 16(3), 546; https://doi.org/10.3390/cancers16030546
Available online: https://www.mdpi.com/2072-6694/16/3/546

2. “Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review”
by Caroline Amélia Gonçalves, Gabriela Pereira-da-Silva, Renata Cristina Campos Pereira Silveira, Paulo César Morales Mayer, Adriana Zilly and Luís Carlos Lopes-Júnior
Cancers 2024, 16(3), 672; https://doi.org/10.3390/cancers16030672
Available online: https://www.mdpi.com/2072-6694/16/3/672

3. “Precision Medicine for Nasopharyngeal Cancer—A Review of Current Prognostic Strategies”
by Luvita Suryani, Hazel P. Y. Lee, Wei Keat Teo, Zhi Kang Chin, Kwok Seng Loh and Joshua K. Tay
Cancers 2024, 16(5), 918; https://doi.org/10.3390/cancers16050918
Available online: https://www.mdpi.com/2072-6694/16/5/918

4. “Activation of Epstein–Barr Virus’ Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and Temozolomide”
by Hannah Hartman-Houstman, Steve Swenson, Radu O. Minea, Uttam K. Sinha, Ming-Fu Chiang, Thomas C. Chen and Axel H. Schönthal
Cancers 2024, 16(5), 936; https://doi.org/10.3390/cancers16050936
Available online: https://www.mdpi.com/2072-6694/16/5/936

5. “Epigenetic Mechanisms in Latent Epstein-Barr Virus Infection and Associated Cancers”
by Atharva S. Torne and Erle S. Robertson
Cancers 2024, 16(5), 991; https://doi.org/10.3390/cancers16050991
Available online: https://www.mdpi.com/2072-6694/16/5/991

6. “Long-Term Survival Rates and Treatment Trends of Burkitt Lymphoma in Patients with HIV—A National Cancer Database (NCDB) Study”
by Clare M. Wieland, Ashley M. Tuin, Elizabeth J. Dort, Alexander G. Hall, Mridula Krishnan and Manasa Velagapudi
Cancers 2024, 16(7), 1397; https://doi.org/10.3390/cancers16071397
Available online: https://www.mdpi.com/2072-6694/16/7/1397

7. “PAX1/JAM3 Methylation and HPV Viral Load in Women with Persistent HPV Infection”
by Mingzhu Li, Chao Zhao, Xiaobo Zhang, Jingran Li, Yun Zhao, Wei Zhang, Lihua Ren and Lihui Wei
Cancers 2024, 16(7), 1430; https://doi.org/10.3390/cancers16071430
Available online: https://www.mdpi.com/2072-6694/16/7/1430

8. “Hepatitis-C-Related Hepatocellular Carcinoma, Still a Relevant Etiology beyond a Hepatitis C Infection Cure”
by Elena Vargas-Accarino, Mónica Higuera, María Buti and Beatriz Mínguez
Cancers 2024, 16(8), 1521; https://doi.org/10.3390/cancers16081521
Available online: https://www.mdpi.com/2072-6694/16/8/1521

9. “HPV DNA Integration at Actionable Cancer-Related Genes Loci in HPV-Associated Carcinomas”
by Xavier Sastre-Garau, Lilia Estrada-Virrueta and François Radvanyi
Cancers 2024, 16(8), 1584; https://doi.org/10.3390/cancers16081584
Available online: https://www.mdpi.com/2072-6694/16/8/1584

10. “Seroprevalence of SARS-CoV-2 and Hepatitis B Virus Coinfections among Ethiopians with Acute Leukemia”
by Jemal Alemu, Balako Gumi, Aster Tsegaye, Ziyada Rahimeto, Dessalegn Fentahun, Fozia Ibrahim, Abdulaziz Abubeker, Amha Gebremedhin, Tesfaye Gelanew and Rawleigh Howe
Cancers 2024, 16(8), 1606; https://doi.org/10.3390/cancers16081606
Available online: https://www.mdpi.com/2072-6694/16/8/1606

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.